Log in to save to my catalogue

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular pati...

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular pati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10103030

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients

About this item

Full title

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients

Publisher

England: BioMed Central Ltd

Journal title

BMC pharmacology & toxicology, 2023-04, Vol.24 (1), p.24-24, Article 24

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Renin-angiotensin-aldosterone system (RAAS) is hypothesized to be in the center of COVID pathophysiology as the angiotensin converting enzyme 2 (ACE2) represents the main entrance of the virus, thus there is a need to address the effect of chronic use of RAAS blockers, as in case of treatment of cardiovascular diseases, on the expression of ACE2. A...

Alternative Titles

Full title

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10103030

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10103030

Other Identifiers

ISSN

2050-6511

E-ISSN

2050-6511

DOI

10.1186/s40360-023-00667-w

How to access this item